Novoron Bioscience

About:

Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.

Website: http://www.novoron.com

Twitter/X: novoronbio

Top Investors: National Institutes of Health, Two Bear Capital, Backstage Capital

Description:

Novoron Bioscience develops new therapeutic approaches to address neurological damage or disease in the central nervous system (CNS). Our novel LRP-focused science enables hope for treatment of conditions for which no current therapies exist. We’re advancing multiple biological therapeutics that treat pathologies of the CNS, including tauopathies (Alzheimer’s, CTE, TBI, etc.), acute spinal cord injury (orphan drug indication), and demyelinating conditions (multiple sclerosis, NMO, etc.).